Zonisamide

Chemical formula: C₈H₈N₂O₃S  Molecular mass: 212.226 g/mol  PubChem compound: 5734

Therapeutic indications

Zonisamide is indicated for:

Partial seizures

Population group: only adults (18 years old or older)

Zonisamide is indicated as:

  • monotherapy in the treatment of partial seizures, with or without secondary generalisation, in adults with newly diagnosed epilepsy;
  • adjunctive therapy in the treatment of partial seizures, with or without secondary generalisation, in adults, adolescents, and children aged 6 years and above.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Partial seizures

Population group: only children (1 year - 12 years old) , adolescents (12 years - 18 years old)

Zonisamide is indicated as:

  • monotherapy in the treatment of partial seizures, with or without secondary generalisation, in adults with newly diagnosed epilepsy;
  • adjunctive therapy in the treatment of partial seizures, with or without secondary generalisation, in adults, adolescents, and children aged 6 years and above.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Summary of Product Characteristics (SPC) 2023: ZONEGRAN Hard capsule
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈